NASDAQ:FTXH First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News $41.28 +0.85 (+2.09%) As of 10:19 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort Interest About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FTXH alerts:Sign Up Key Stats Today's Range$40.44▼$40.9450-Day Range$39.15▼$42.7652-Week Range$28.85▼$43.52Volume2,866 shsAverage Volume233,358 shsMarket Capitalization$1.06 billionAssets Under Management$1.07 billionDividend Yield0.70%Net Expense Ratio0.60%Aggregate RatingModerate Buy ETF Overview The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust. Read More First Trust Nasdaq Pharmaceuticals ETF ExpensesTypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.55%0.57%0.54%0.53%Other Expenses0.00%0.52%0.53%0.38%0.54%Total Expense0.60%0.76%0.75%0.69%0.73%Fee Waiver0.00%-0.85%-0.67%-0.41%-0.68%Net Expense0.60%0.58%0.63%0.61%0.60% Receive FTXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FTXH ETF News HeadlinesTrump to announce discount drug pricing expansion, White House official saysMay 18, 2026 | reuters.comFirst Trust Nasdaq BuyWrite Income ETF declares $0.207 dividendJanuary 22, 2025 | msn.comThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets.October 14 at 1:00 AM | Behind the Markets (Ad)3 Health Care ETFs You'll Want to Own When the Market RecoversAugust 3, 2022 | stocknews.comSurprising Analyst 12-Month Target For FTXHMay 25, 2022 | nasdaq.comFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488March 25, 2022 | seekingalpha.comSee More Headlines FTXH ETF - Frequently Asked Questions How have FTXH shares performed this year? First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $32.9960 at the beginning of 2026. Since then, FTXH shares have increased by 22.5% and is now trading at $40.43. How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF? Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerFirst Trust Fund NameFirst Trust Nasdaq Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FTXH Inception Date9/20/2016 Fund ManagerDaniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkNasdaq US Smart Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings51 Fund Statistics Assets Under Management$1.07 billion Average Daily Volume$319.61 thousand Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest9,470 shs Miscellaneous Outstanding Shares25,800,000Beta0.45 Creation Unit50,000 Creation Fee$500.00 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report Top 10 FTXH HoldingsAbbVie (NYSE:ABBV)Holding Weight: 7.79%Eli Lilly and Company (NYSE:LLY)Holding Weight: 7.41%Pfizer (NYSE:PFE)Holding Weight: 7.16%Johnson & Johnson (NYSE:JNJ)Holding Weight: 7.07%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 7.06%Viatris (NASDAQ:VTRS)Holding Weight: 3.87%Biogen (NASDAQ:BIIB)Holding Weight: 3.69%Gilead Sciences (NASDAQ:GILD)Holding Weight: 3.68%Amgen (NASDAQ:AMGN)Holding Weight: 3.47%Zoetis (NYSE:ZTS)Holding Weight: 3.47%Full Holdings DetailsFTXH Sector ExposureFTXH Industry Exposure This page (NASDAQ:FTXH) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersThe AI Infrastructure Play Kevin O'Leary Is BackingKevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...The Tomorrow Investor | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredAI Microcap Teams With Gentex on Next-Gen Military HelmetsMorgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion...Capital Trends | SponsoredMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a...Crypto 101 Media | SponsoredElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
